samsca
otsuka pharmaceutical netherlands b.v. - tolvaptan - inappropriate adh syndrome - diuretics, - treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (siadh).,
samsca 30mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 30mg
samsca 15mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 15mg
jinarc 15mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 15mg
samsca tablet 15mg
otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 15mg
jinarc tablet 15mg
otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 15mg
jinarc tablet 30mg
otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 30.000mg
jinarc tablet 45mg15mg
otsuka pharmaceuticals (singapore) pte. ltd. - (15mg tablet) tolvaptan; (45mg tablet) tolvaptan - tablet - (15mg tablet) tolvaptan 15.000mg; (45mg tablet) tolvaptan 45.0mg
jinarc tablet 60mg30mg
otsuka pharmaceuticals (singapore) pte. ltd. - (30mg tablet) tolvaptan; (60mg tablet) tolvaptan - tablet - (30mg tablet) tolvaptan 30.000mg; (60mg tablet) tolvaptan 60.000mg
jinarc tablet 90mg30mg
otsuka pharmaceuticals (singapore) pte. ltd. - (30mg tablet) tolvaptan; (90mg tablet) tolvaptan - tablet - (30mg tablet) tolvaptan 30.000mg; (90mg tablet) tolvaptan 90.0mg